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INTRODUCTION
Melioidosis is predominantly a tropical disease and most
cases are reported during the rainy season in endemic area. It
is characterized by abscess-formation in the lung, liver, spleen,
skeletal muscle and prostate with the lung being the most
commonly involved organ. The clinical features are variable
from rapidly progressing septicemia to chronic debilitating
abscess-forming disease. Understanding about melioidosis is
important in tuberculosis endemic areas, because its progres-
sion and roentgenographic findings are so similar to tuber-
culosis that it is not rare for melioidosis to be misdiagnosed
as tuberculosis. We report a case of melioidosis presenting as
intermittent fever and migrating pulmonary infiltration. The
patient was a 50-yr-old man who was diagnosed with melioi-
dosis on bronchoscopic washing culture and whose symptoms
improved after treatment with high dose ceftazidime. 
CASE REPORT
A 50-yr-old man visited our hospital because of intermit-
tent fever associated with cough, sputum, generalized myal-
gia and general weakness for about four weeks. He had lived
in Indonesia for twenty years for business, and visited a local
hospital in Indonesia and was treated for typhoid fever with-
out improvement of symptoms. He was previously healthy
and had no history of diabetes. Initial chest radiograph and
computed tomography (CT) images showed multiple satel-
lite nodules in the left lower and upper lobes, and judging
from that roentgenographic examination, tuberculosis was the
most probable diagnosis (Fig. 1). Bronchoscopy showed no
endobronchial lesion and washing cytology and culture were
also negative. We prescribed moxifloxacin but his symptoms
showed no improvement. Three months later we rechecked
chest radiograph and CT findings, and found new infiltration
in the left lower lobe and improvement of lesions in the left
upper and lower lobes (Fig. 2). So he was admitted to our hos-
pital for further evaluation. On physical examination initial
body temperature was 38℃ and there was no other abnormal
finding. Laboratory findings included white blood cell count
of 5,240/ L and hemoglobin value of 11.6 g/dL. Hepatic func-
tion and renal function were normal. IgA was 227 mg/dL
(normal range: 90-400 mg/dL) and anti-neutrophilic cyto-
plasmic antibodies with cytoplasmic staining pattern (C-
ANCA) was negative.
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A Case of Melioidosis Presenting as Migrating Pulmonary Infiltration:
The First Case in Korea
Melioidosis is an infection of the Gram-negative bacterium Burkholderia pseudoma-
llei. While it is known as an important cause of sepsis or chronic abscess-forming
disease in Southeast Asia and northern Australia, no case has yet been reported in
Korea. A 50-yr-old man visited our hospital for intermittent fever associated with dry
cough and sputum. Roentgenographic examination showed migrating pulmonary
infiltration. Symptoms and chest radiograph and computed tomography (CT) image
findings did not improve despite use of fluoroquinolone antibiotics. Gram-negative
bacteria were isolated on bronchoscopic washing culture and were identified as B.
pseudomallei on DNA sequencing of 16S ribosomal RNA with 100% homology.
Treatment for melioidosis was commenced with high dose ceftazidime, and the pa-
tient’s fever, cough, and sputum were improved and the lesion on chest radiograph
and CT almost disappeared.
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Bronchoscopy was done once more and no endobronchial
lesion was found. However, secretion was seen in left lower
lobe, so washing cytology and culture was done. Cytology was
negative but a species of bacteria grew on blood agar media
(Fig. 3). It was Gram-negative, non-spore forming and showed
as a safety pin shaped organism on microscopic examination
(Fig. 4). By biochemical examination of API20NE strip and
VITEK GNI card (BioMerieux, Inc., Hazelwood, U.S.A.),
the organism was identified as Burkholderia pseudomallei (1).
On DNA sequencing of 16S ribosomal RNA, it was compat-
Fig. 1. Initial CPA and CT images show multiple infiltrations in the left upper and lower lobes.
Fig. 2. Three months later, a new infiltration appears in the left lower lobe and lesions in the left upper and lower lobes improved.
Fig. 3. The colonies develop a rugose appearance, and they take
up violet dye from medium after 2 days at 35 ° C.
Fig. 4. Gram stain shows Gram-negative safety pin shaped organ-
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ible with B. pseudomallei with 100% homology and formed
a characteristic rugose colony on blood agar.
We prescribed ceftazidime 2 g intravenously every 8 hr and
he did not complain of intermittent fever any more. The cough,
sputum and general condition improved slowly. After one
week of intravenous ceftazidime, he was discharged with oral
amoxicillin-clavulanate (750 mg every 8 hr). One month later
the cough and sputum were almost disappeared but his gen-
eral weakness persisted although it was also improving.
Four months later we rechecked chest CT to show an im-
provement of infiltration in left lower lobe. He said his con-
dition was as good as his previous state before suffering from
melioidosis. One month later, we stopped administrating oral
antibiotics to him, which resulted in him taking amoxicillin-
clavulanate for total five months.
DISCUSSION
This is the first case report of melioidosis in Korea. The
endemic area includes Southeast Asia, North Australia, Mada-
gascar, and Guam (2). In northeast Thailand, melioidosis ac-
counts for 20% of all community-acquired septicemias, and
causes death in 40% of treated patients.
Melioidosis was first described by Whitmore in 1911 and
more than 100 cases had been reported by 1917 (3). Since
then, with sporadic cases being reported during and after
World War II and many soldiers fighting in Vietnam suffer-
ing from this disease, Western countries began to take an in-
terest in melioidosis. 
B. pseudomallei is a motile aerobic, non-spore-forming and
Gram-negative bacillus. The colonies develop a rugose appear-
ance, and take up crystal violet dye from the medium. Gram
stain shows Gram-negative rods with bipolar staining. It is
resistant to many antibiotics. Although it is Gram-negative
bacterium, it is usually resistant to aminoglycoside, 1st & 2nd
cephalosporin, macrolide, rifamycin and colistin, but is sus-
ceptible to ampicillin/sulbactam, chloramphenicol, tetracy-
cline, bactrim, 3rd cepha and carbapenem (4). B. pseudomallei
is a soil saprophyte and can be recovered readily from water
and wet soils in rice paddy fields. For example, in Thailand
the organism can be cultured readily from more than 50% of
rice paddies (5). 
Melioidosis is acquired by inoculation or inhalation, but
not by ingestion. Vertical transmission at childbirth and sex-
ual transmission have also been reported (6). Melioidosis has
a wide range of clinical manifestations. It presents as a febrile
illness, ranging from an acute fulminant sepsis to a chronic
debilitating localized infection. The disease is characterized
by abscess formation. The lung is the most commonly affected
organ, either presenting with cough and fever resulting from
a primary lung abscess or pneumonia. Seeding and abscess
formation can arise in any organ, and the liver, spleen, skeletal
muscle and prostate are common sites. 
Localized pulmonary melioidosis often cannot be differen-
tiated from tuberculosis on clinical and chest radiography
findings. However, melioidosis differs from tuberculosis in
the following ways. First, some melioidosis cases have rapid
clinical and roentgenographic progression within a few days.
Second, melioidosis usually responds to treatment well and
has apparent roentgenographic improvement within 1-2
weeks. Third, parapneumonic effusion develops in 5-15%
of cases, but the amount is not large and associated pulmonary
infiltration is always present. In contrast, tuberculosis pleurisy
in which a large amount of pleural fluid is present without
underlying pulmonary infiltration is common. Fourth, hilar
adenopathy is very rare in melioidosis (7). 
Diagnosis of melioidosis is made by isolation of B. pseudo-
mallei from any site; for example blood, sputum, abscess fluid
and throat swab. The organism is not carried asymptomati-
cally (8). Abdominal ultrasound should be done in all suspect-
ed cases. Since splenic abscess is much less common in other
diseases, its presence is more likely to suggest melioidosis.
Serologic test is nonspecific but can be used to exclude this
disease. 
The antibiotic of choice is ceftazidime (40 mg/kg intrave-
nous injection every 8 hr), while other 3rd generation cepha-
losporin is less effective (9). Intravenous antibiotic is usually
given for more than 10 days until clinical improvement. After
clinical improvement, patients can take oral antibiotics. Four-
drug combination is usually recommended as oral antibiotics,
and those are chloramphenicol (40 mg/kg per day in four
divided doses), doxycycline (4 mg/kg per day in two divided
doses), trimethoprim-sulfamethoxazole (10 mg and 50 mg/kg
per day, respectively, in two divided doses). But in case of chil-
dren and women, amoxicillin-clavulanate is recommended.
Oral treatment is usually continued for twenty weeks. In brief,
high dose ceftazidime followed by long term oral antibiotics
is considered to be most effective treatment. The abscess should
be drained if it is accessible and large.
The distribution and frequency of melioidosis is probably
greatly underestimated (10). In tuberculosis endemic areas,
it is important to understand melioidosis and differentiate
this disease from tuberculosis because the treatment of the
two diseases is completely different.
REFERENCES
1. Coenye T, Goris J, Spilker T, Vandamme P, LiPuma JJ. Character-
ization of unusual bacteria isolated from respiratory secretions of
cystic fibrosis patients and description of Inquilinus limosus gen. nov.,
sp. nov. J Clin Microbiol 2002; 40: 2062-9.
2. Currie BJ, Fisher DA, Howard DM, Burrow JN, Lo D, Selva-Nayagam
S, Anstey NM, Huffam SE, Snelling PL, Marks PJ, Stephens DP,
Lum GD, Jacups SP, Krause VL. Endemic melioidosis in tropical
northern Australia; a 10 year prospective study and review of the
literature. Clin Infect Dis 2000; 31: 981-6.142 S.W. Lee, J. Yi, S.-I. Joo, et al.
3. Krishnaswami CS. Morphia injectors septicemia. Indian med Gaz
1917; 52: 296-9.
4. Jenney AW, Lum G, Fisher DA, Currie BJ. Antibiotic susceptibility
of Burkholderia pseudomallei from tropical northern Australia and
implications for therapy of melioidosis. Int J Antimicrob Agents 2001:
17: 109-13.
5. Wuthiekanun V, Smith MD, Dance DA, White NJ. The isolation of
Pseudomonas pseudomallei from soil in Northeastern Thailand. Trans
R Soc Trop Med Hyg 1995; 89: 41-3.
6. Abbink FC, Orendi JM, de Beaufort AJ. Mother-to-child transmission
of Burkholderia pseudomallei. N Eng J Med 2001; 344: 1171-2.
7. Sumalee Kiatboonsri. Melioidosis. Lung Disease in the Tropics 1990;
51: 135-55.
8. White NJ. Melioidosis. Lancet 2003; 361: 1715-22.
9. White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun
V, Pitakwatchara N. Halving of mortality of severe melioidosis by
ceftazidime. Lancet 1989; 2: 697-701.
10. Angus BJ, Smith MD, Suputtamongkol Y, Mattie H, Walsh AL, Wu-
thiekanun V, Chaowagul W, White NJ. Pharmacokinetic-, pharma-
codynamic evaluation of ceftazidime continuous infusion versus inter-
mittent bolus injection in septicaemic melioidosis. Br J Clin Pharma-
col 2000; 50: 184-91.